Successful Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin Retreatment for a Chronic Hepatitis C Genotype 2a Patient Who Relapsed after Sofosbuvir Plus Ribavirin Treatment. [electronic resource]
Producer: 20181217Description: 2843-2845 p. digitalISSN:- 1349-7235
- Aged
- Anilides -- therapeutic use
- Antiviral Agents -- therapeutic use
- Carbamates -- therapeutic use
- Cyclopropanes
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Lactams, Macrocyclic
- Macrocyclic Compounds -- therapeutic use
- Proline -- analogs & derivatives
- Retreatment
- Ribavirin -- therapeutic use
- Ritonavir -- therapeutic use
- Sofosbuvir -- therapeutic use
- Sulfonamides
- Treatment Outcome
- Valine
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.